Cargando…
Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known met...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714147/ https://www.ncbi.nlm.nih.gov/pubmed/31516377 http://dx.doi.org/10.4103/wjnm.WJNM_11_19 |
_version_ | 1783447000387158016 |
---|---|
author | Schmidt, Matthew Q Trenbeath, Zachary Chin, Bennett B |
author_facet | Schmidt, Matthew Q Trenbeath, Zachary Chin, Bennett B |
author_sort | Schmidt, Matthew Q |
collection | PubMed |
description | The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known metastatic NET who underwent (68)Ga DOTATATE PET/CT for restaging, incidentally revealing intense uptake of the prostate with a maximum standard uptake value of 17.4. Due to the patient's medical history, this finding was concerning for neuroendocrine prostate cancer. However, core biopsies of the prostate were negative for malignancy and positive for chronic inflammation. Chronic prostatitis is a very common condition in adult males and is often asymptomatic. Inflammatory conditions, including prostatitis, are important causes of false-positive findings on (68)Ga DOTATATE PET/CT and should be considered as part of the differential diagnosis, even in an asymptomatic patient. |
format | Online Article Text |
id | pubmed-6714147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67141472019-09-12 Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor Schmidt, Matthew Q Trenbeath, Zachary Chin, Bennett B World J Nucl Med Case Report The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known metastatic NET who underwent (68)Ga DOTATATE PET/CT for restaging, incidentally revealing intense uptake of the prostate with a maximum standard uptake value of 17.4. Due to the patient's medical history, this finding was concerning for neuroendocrine prostate cancer. However, core biopsies of the prostate were negative for malignancy and positive for chronic inflammation. Chronic prostatitis is a very common condition in adult males and is often asymptomatic. Inflammatory conditions, including prostatitis, are important causes of false-positive findings on (68)Ga DOTATATE PET/CT and should be considered as part of the differential diagnosis, even in an asymptomatic patient. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6714147/ /pubmed/31516377 http://dx.doi.org/10.4103/wjnm.WJNM_11_19 Text en Copyright: © 2019 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Schmidt, Matthew Q Trenbeath, Zachary Chin, Bennett B Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title | Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title_full | Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title_fullStr | Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title_full_unstemmed | Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title_short | Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
title_sort | neuroendocrine prostate cancer or prostatitis? an unusual false positive on gallium-68 dota-tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714147/ https://www.ncbi.nlm.nih.gov/pubmed/31516377 http://dx.doi.org/10.4103/wjnm.WJNM_11_19 |
work_keys_str_mv | AT schmidtmatthewq neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor AT trenbeathzachary neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor AT chinbennettb neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor |